A Stability Failure Recall Shows Why Storage and Transport Controls Matter
The MHRA issued a Class 2 Medicines Recall for one batch of Human Rabies Immunoglobulin 500IU solution for injection after a stability failure showed a reduction in potency.
Healthcare professionals were told to stop supplying the affected batch immediately, quarantine all stock and return it through the supplier’s approved process. The MHRA notice also confirmed that 1,414 packs of the affected batch had been released and distributed, with no related adverse event reports received.
For patients and healthcare professionals, this type of recall is about preventing potential loss of clinical effectiveness.
For medicines wholesale businesses, it is also a reminder of something very important:
Storage, transport, stock control and escalation processes must work in real life.
What Happened and Why It Matters
The affected product was recalled because a stability failure showed reduced potency.
Potency matters because medicines need to remain suitable and effective throughout their shelf life and supply journey.
The MHRA notice made clear that the recall was intended to prevent any potential reduction in clinical effectiveness of the product, and that affected stock should be quarantined and returned.
That gives medicines wholesale businesses a practical lesson.
When a quality issue is identified, the business needs to act quickly and in a controlled way.
It needs to know where the affected stock is, whether it has been supplied, who received it, how to stop supply, how to quarantine stock and how to record the action taken.
What This Means for Medicines Wholesale Businesses
GDP compliance is not only about having a licence or writing SOPs.
It is about making sure medicines are handled properly throughout the supply chain.
Official MHRA guidance explains that GDP requires medicines to be obtained from the licensed supply chain and consistently stored, transported and handled under suitable conditions, as required by the marketing authorisation or product specification.
That means a business should be able to show control over:
- Stock receipt
- Storage conditions
- Temperature monitoring where required
- Transport arrangements
- Supplier communication
- Customer communication
- Quarantine processes
- Recall response
- Records and traceability
- Responsible Person oversight
If any of these areas are weak, the business may struggle when a recall or quality defect appears.
Why Stability and Potency Issues Matter
A stability issue can raise questions about whether the product remains suitable for use.
For a wholesaler, the question is not only why the defect happened.
The question is whether the business can respond properly once it knows about it.
- Can the business identify affected stock?
- Can it stop supply immediately?
- Can it quarantine stock correctly?
- Can it contact customers where needed?
- Can it follow supplier instructions?
- Can it evidence what happened?
- Can the Responsible Person see and oversee the response?
These questions matter because recalls and defects test the quality system.
They show whether procedures are practical or just written down.
Why Storage and Transport Controls Matter
Storage and transport controls help protect medicine quality.
If the wrong conditions are used, or if conditions are not monitored properly, the business may not be able to show that the product remained suitable during its time in the supply chain.
The MHRA says inspections may include review of stock management, storage areas, temperature monitoring, returns areas, purchasing and sales functions, transportation arrangements, documents and relevant personnel.
That is why storage and transport should never be treated as background operations.
They are part of the compliance foundation.
What Businesses Should Check Now
If your business is involved in medicines wholesale, WDA(H) readiness, specialist distribution or ongoing GDP compliance, this is a good time to review your storage, transport and quarantine controls.
Start with these checks:
- Review how affected batches are identified.
- Check whether stock location records are accurate.
- Review quarantine procedures.
- Check whether staff know how to stop supply quickly.
- Review temperature monitoring processes.
- Check whether transport arrangements are documented.
- Review supplier and customer communication routes.
- Check whether the Responsible Person has clear visibility.
- Review how recalls and quality defects are recorded.
- Check whether CAPA is considered after defects or repeated issues.
These checks are not about creating unnecessary paperwork.
They are about making sure the business can act quickly, clearly and defensibly when quality risks appear.
How Stag Global Helps
Stag Global does not supply medicines or products.
We support businesses with compliance-led review and readiness support.
This may include:
- GDP audit and readiness support
- Storage and transport control review
- Responsible Person / GDP quality support
- Recall readiness review
- SOP and documentation review
- Stock quarantine process review
- Compliance route reviews
- WDA(H) application readiness
- Ongoing compliance support
Our role is to help businesses understand whether their systems are clear, practical and ready to support regulated medicines activity.
We help clients identify what is working, what may be missing and what needs strengthening.
Final Thought
A stability failure recall is not only a product issue.
It is a system test.
It tests whether the business can identify affected stock, stop supply, quarantine products, follow instructions, communicate clearly and record actions properly.
For medicines wholesale businesses, the key question is simple:
Can your business evidence, control and defend how medicines are stored, transported and handled?
If the answer is unclear, now is the time to review your systems.
Need clarity on your storage controls, transport arrangements, recall readiness or GDP systems?
Book a confidential consultation with Stag Global to review your compliance position before pressure arrives.
